BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//wp-events-plugin.com//7.2.3.1//EN
BEGIN:VEVENT
UID:83@myasthenia.org
DTSTART;TZID=America/New_York:20220222T230000
DTEND;TZID=America/New_York:20220223T000000
DTSTAMP:20241028T210258Z
URL:https://myasthenia.org/events/mgfa-whats-new-in-mg-research-webinar-we
 binar-presentation-of-newly-fda-approved-vyvgart-2022-02-22/
SUMMARY:MGFA "What's New in MG Research" Webinar: Webinar presentation of n
 ewly FDA Approved\n        VYVGART™
DESCRIPTION:Date/Time: Tuesday\, February 22nd 2022 at 3:00 p.m. Eastern Pr
 esenter: Dr. Deborah Gelinas\, MD\, Executive Director of Neuromuscular Me
 dicine for Argenx. Webinar presentation of newly FDA Approved VYVGART&trad
 e\; (efgartigimod alfa-fcab) for the treatment of adult patients with gMG 
 who are anti-AChR antibody positive       
ATTACH;FMTTYPE=image/jpeg:https://myasthenia.org/wp-content/uploads/Portal
 s/0/EasyDNNNews/203/img-event-research1-2.jpg
CATEGORIES:Events,Webinars
END:VEVENT
BEGIN:VTIMEZONE
TZID:America/New_York
X-LIC-LOCATION:America/New_York
BEGIN:STANDARD
DTSTART:20211107T010000
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
END:STANDARD
END:VTIMEZONE
END:VCALENDAR